Hynion AS
OSE:HYN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hynion AS
OSE:HYN
|
NO |
|
V
|
Vanda Pharmaceuticals Inc
SWB:VM4
|
US |
|
C
|
China Vered Financial Holding Corporation Ltd
HKEX:2451
|
HK |
|
E
|
Elisa Oyj
LSE:0I8Y
|
FI |
|
D
|
Dcm Shriram Industries Ltd
BSE:523369
|
IN |
Income Statement
Earnings Waterfall
Hynion AS
Income Statement
Hynion AS
| Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | ||
|---|---|---|---|---|---|
| Revenue | |||||
| Interest Expense |
0
|
0
|
0
|
0
|
|
| Revenue |
4
N/A
|
5
+14%
|
5
-2%
|
6
+37%
|
|
| Gross Profit | |||||
| Cost of Revenue |
(8)
|
(9)
|
(7)
|
(2)
|
|
| Gross Profit |
(4)
N/A
|
(4)
-9%
|
(2)
+52%
|
2
N/A
|
|
| Operating Income | |||||
| Operating Expenses |
(24)
|
(27)
|
(27)
|
(27)
|
|
| Selling, General & Administrative |
(11)
|
(14)
|
(13)
|
(9)
|
|
| Depreciation & Amortization |
(2)
|
(2)
|
(2)
|
(2)
|
|
| Other Operating Expenses |
(11)
|
(11)
|
(12)
|
(16)
|
|
| Operating Income |
(28)
N/A
|
(31)
-11%
|
(29)
+9%
|
(23)
+20%
|
|
| Pre-Tax Income | |||||
| Interest Income Expense |
0
|
(0)
|
(0)
|
(0)
|
|
| Non-Recurring Items |
(1)
|
0
|
(4)
|
0
|
|
| Total Other Income |
(0)
|
0
|
0
|
(1)
|
|
| Pre-Tax Income |
(29)
N/A
|
(31)
-7%
|
(32)
-3%
|
(24)
+27%
|
|
| Net Income | |||||
| Income from Continuing Operations |
(29)
|
(31)
|
(32)
|
(24)
|
|
| Net Income |
(29)
N/A
|
(31)
-7%
|
(32)
-3%
|
(24)
+27%
|
|
| EPS (Diluted) |
-0.28
N/A
|
-0.3
-7%
|
-0.3
N/A
|
-0.22
+27%
|
|